HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shiseido

This article was originally published in The Rose Sheet

Executive Summary

Company acquires 40% share of Mandara Spa under deal announced May 17. The agreement will allow Honolulu-based Mandara to expand its 30-spa portfolio with 20 additional locations in the next five years

You may also be interested in...



Shiseido's Decleor Stake Signifies Aromatherpy Market Commitment

Shiseido's acquisition of French spa company Decleor indicates the Japanese cosmetics firm's dedication to the aromatherapy market as well as its long-standing global multibrand strategy. Shiseido purchased a 75% stake in the company in a deal announced May 15.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008028

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel